Cover Image
市場調查報告書

RNA干擾 (RNAi) 技術市場預測:各用途 (研究開發,治療方法,藥物研發,農業) 、各工具 (設計/軟體,提供基礎,監測,圖書館) 、各地區

Ribonucleic Acid Interference (RNAi) Technology Market: By Application (Research and Development, Therapeutics, Drug Discovery, Agriculture), By Tools (Design/Software, Delivery Based, Monitoring, Libraries) & By Region-Forecast (2016-2021)

出版商 IndustryARC 商品編碼 422491
出版日期 內容資訊 英文 132 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
RNA干擾 (RNAi) 技術市場預測:各用途 (研究開發,治療方法,藥物研發,農業) 、各工具 (設計/軟體,提供基礎,監測,圖書館) 、各地區 Ribonucleic Acid Interference (RNAi) Technology Market: By Application (Research and Development, Therapeutics, Drug Discovery, Agriculture), By Tools (Design/Software, Delivery Based, Monitoring, Libraries) & By Region-Forecast (2016-2021)
出版日期: 2016年10月06日 內容資訊: 英文 132 Pages
簡介

本報告提供全球RNA干擾 (RNAi) 技術市場相關調查分析,市場形勢,市場動態,策略性分析,市場分析 (各市場區隔)等,主要企業等相關的系統性資訊。

第1章 RNA干擾 (RNAi) 技術:市場概要

第2章 摘要整理

第3章 市場形勢

  • 市場佔有率分析
  • 比較分析
  • 產品基準
  • 終端用戶分析
  • 5大財務分析

第4章 RNA干擾 (RNAi) 技術:市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場課題
  • 波特的五力分析

第5章 RNA干擾 (RNAi) 技術市場:策略性分析

  • 價值鏈分析
  • 價格分析
  • 機會分析
  • 產品/市場生命週期分析
  • 供應商、經銷商

第6章 RNA干擾 (RNAi) 技術市場:各工具

  • 設計/軟體
  • 提供基礎
  • 監測
  • 圖書館
  • 其他

第7章 RNA干擾 (RNAi) 技術市場:各用途

  • 研究開發
  • 治療方法
  • 藥物研發
  • 農業
  • 其他

第8章 RNA干擾 (RNAi) 技術市場:各地區

  • 歐洲
  • 亞太地區
  • 北美
  • 其他

第9章 RNA干擾 (RNAi) 技術市場:市場熵

  • 產業擴大
  • 技術開發
  • 新產品銷售
  • M&A,合資企業
  • 供給契約

第10章 企業簡介

  • Rosetta Genomics
  • Exiqon A/S
  • Merck KGaA
  • Pfizer Inc.
  • F. Hoffmann-La Roche AG
  • Alnylam pharmaceuticals
  • Arrowhead research corporation
  • Quark pharmaceuticals inc
  • Rxi pharmaceuticals corp.
  • Silence therapeutics
  • Tekmira pharmaceuticals corp
  • Thermo fisher scientific inc

第11章 附錄

目錄

RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics. Globally increasing R&D activities in the field of RNAi activities is expected to be the key growth driver during the period of study.

Geographically North America dominated RNAi technology market owing to the large scale of its pharmaceutical industry which invests heavily in R&D activities to formulate and update new therapies. North America was followed by Europe and Asia-Pacific as second and third largest market for RNAi technology market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing pharmaceutical industrial infrastructure which has attracted many global industry player, government initiatives and in developing nations such as China, and India in this region.

This report identifies the global RNAi technology market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global RNAi technology market.

This report segments global RNAi technology market on the basis of application, tools and regional market as follows:

RNAi Technology Market research report is classified on the basis of applications of RNAi technology in wide range of industries some of the major applications of RNAi Technology covered in this report are as follows: Research and Development, Therapeutics, Drug Discovery, Agriculture and Others

RNAi technology market research report is classified on the basis of tools of RNAi technology in wide range of industries some of the major applications of RNAi technology covered in this report are as follows: Design/Software, Delivery Based, Monitoring, Libraries

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the RNAi technology market. Some of the major companies' profiles in detail are as follows:

F. Hoffmann-La Roche AG

Alnylam pharmaceuticals

Arrowhead research corporation

Quark pharmaceuticals inc

Rxi pharmaceuticals corp.

Table of Contents

1. RNAi Technology Market - Market Overview

2. Executive Summary

3. Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. RNAi Technology Market- Market Forces

  • 4.1. Drivers
    • 4.1.1. Increasing R&D activities in the field of RNAi
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. RNAi Technology Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. RNAi Technology Market, By Tools

  • 6.1. Design/Software
  • 6.2. Delivery Based
  • 6.3. Monitoring
  • 6.4. Libraries
  • 6.5. Others

7. RNAi Technology Market, By Applications

  • 7.1. Research and Development
  • 7.2. Therapeutics
  • 7.3. Drug Discovery
  • 7.4. Agriculture
  • 7.5. Others

8. RNAi Technology Market, By Geography

  • 8.1. Europe
    • 8.1.1. Germany
    • 8.1.2. France
    • 8.1.3. Italy
    • 8.1.4. Spain
    • 8.1.5. Russia
    • 8.1.6. U.K.
    • 8.1.7. Rest of Europe
  • 8.2. Asia Pacific
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Japan
    • 8.2.4. South Korea
    • 8.2.5. Rest of Asia-Pacific
  • 8.3. North America
    • 8.3.1. U.S.
    • 8.3.2. Canada
    • 8.3.3. Mexico
  • 8.4. Rest of the World (RoW)
    • 8.4.1. Brazil
    • 8.4.2. Rest of RoW

9. RNAi Technology Market - Market Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 10.1. Rosetta Genomics
  • 10.2. Exiqon A/S
  • 10.3. Merck KGaA
  • 10.4. Pfizer Inc.
  • 10.5. F. Hoffmann-La Roche AG
  • 10.6. Alnylam pharmaceuticals
  • 10.7. Arrowhead research corporation
  • 10.8. Quark pharmaceuticals inc
  • 10.9. Rxi pharmaceuticals corp.
  • 10.10. Silence therapeutics
  • 10.11. Tekmira pharmaceuticals corp
  • 10.12. Thermo fisher scientific inc

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer
Back to Top